HealthcareServices

Prenatal And Newborn Genetic Testing Market Future Outlook 2026: Key Drivers and Growth Potential

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal and newborn genetic testing market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Prenatal And Newborn Genetic Testing Market’s size between 2026 and 2030?

The market size for prenatal and newborn genetic testing has experienced rapid growth in recent years. This market is expected to expand from $7.6 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The historical growth of this market can be attributed to various factors such as increased awareness of genetic disorders, the expansion of maternal and neonatal healthcare services, the emergence of more institutional screening programs, the greater availability of diagnostic laboratories, and enhancements in the accuracy of genetic testing.

The prenatal and newborn genetic testing market is anticipated to experience substantial expansion over the next few years. This market is projected to reach $13.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine approaches, a rising demand for early-stage disease detection, the expansion of newborn screening mandates, growing investments in genomics infrastructure, and the increasing use of digital health platforms. Prominent trends expected in this period include the increasing adoption of non-invasive prenatal testing, a rising use of advanced genetic screening panels, the growing integration of AI in genetic risk analysis, the expansion of high-throughput sequencing platforms, and an enhanced focus on the early detection of congenital disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Drivers Are Shaping Strategic Decisions In The Prenatal And Newborn Genetic Testing Market?

The anticipated expansion of the prenatal and newborn genetic testing market is linked to the increasing occurrence of genetic disorders. These conditions are defined as health issues stemming from alterations or defects in a person’s DNA or genetic makeup. Such testing, conducted both prenatally and in newborns, facilitates the early detection of genetic disorders, frequently prior to symptom onset, allowing medical professionals to implement prompt interventions and treatment approaches. As an illustration, the Centers for Disease Control and Prevention (CDC), a US public health agency, reported in May 2024 that approximately 100,000 individuals in the United States are affected by sickle cell disease (SCD). Over 90% of those impacted are non-Hispanic Black or African American, and an estimated 3%-9% are Hispanic or Latino. Consequently, the growing frequency of genetic disorders is a key driver for the prenatal and newborn genetic testing market.

What Segment Categories Are Covered In The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments

2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings

3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia

4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Upcoming Trends Are Likely To Define The Future Path Of The Prenatal And Newborn Genetic Testing Market?

Leading companies operating within the prenatal and newborn genetic testing markets are primarily focused on developing innovative screening tests, such as noninvasive prenatal screening tests, enhancing their accessibility and affordability to deliver dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), represents a highly advanced and secure genetic screening methodology conducted during pregnancy to assess the likelihood of specific fetal chromosomal abnormalities. As an illustration, in January 2024, Natera, Inc., a genetic testing company based in the US, launched a fetal RhD NIPT designed to determine fetal RhD status, thereby assisting obstetricians in managing patient care during prevalent Rho(D) immune globulin (RhIg) shortages across the nation. This particular test is underpinned by a comprehensive clinical validation study that included more than 650 RhD-negative patients with verified outcomes, achieving a 100% sensitivity and >99% specificity. Furthermore, Natera’s test offers the advantage of early pregnancy performance, supporting timely clinical decisions and improving patient management.

Which Major Industry Participants Are Leading The Prenatal And Newborn Genetic Testing Market Growth?

Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Prenatal And Newborn Genetic Testing Market?

North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Prenatal And Newborn Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2026, By The Business Research Company

Non Invasive Prenatal Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Prenatal Testing And Newborn Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795